Azenta Sells B Medical Systems Unit for $63M

By Philip Seaworth • Wednesday, July 08 16:01 • Permanent Link

Azenta completed the sale of its B Medical Systems business on July 1, 2026, after announcing the deal on December 29, 2025.

The company said the unit was sold to Thelema S.à r.l. for a fixed cash purchase price of $63 million. Of that amount, $35 million was funded through a short-term secured vendor loan provided by an Azenta subsidiary to Thelema.

Azenta said the transaction was completed after all closing conditions were satisfied. The company said the sale is part of its effort to simplify its portfolio and focus on its core life sciences businesses. Today the company's shares have moved -3.0% to a price of $24.61. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.